Evaluation of Chitinase 3-like 1 (CHI3L1) as a noninvasive biomarker of hepatic fibrosis in patients with Hepatitis B virus–related compensated chronic liver disease

BACKGROUND: Liver biopsy is the gold-standard method for diagnosing and staging liver fibrosis, but the procedure is invasive, not available in the primary health care facilities, and not free from complications. Noninvasive serum biomarkers of hepatic fibrosis are the current research focus. OBJECT...

Descripción completa

Detalles Bibliográficos
Autores principales: Das, Amit, Kamrul-Hasan, ABM, Kabir, Mohammed Ruhul, Das, Shantanu, Zaki, KMJ, Al Mahtab, Mamun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8144771/
https://www.ncbi.nlm.nih.gov/pubmed/34123914
http://dx.doi.org/10.4103/jfmpc.jfmpc_1922_20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8144771/
https://www.ncbi.nlm.nih.gov/pubmed/34123914
http://dx.doi.org/10.4103/jfmpc.jfmpc_1922_20

Ejemplares similares